Uematsu, Atsushi <br/><br/>
DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma.  [electronic resource] 

 -  Biochemical and biophysical research communications  01 2018 
 - 2289-2295 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2017.12.142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis--drug effects<br/>Bortezomib--administration & dosage<br/>Cell Line, Tumor<br/>Diamines--administration & dosage<br/>Drug Synergism<br/>Female<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Multiple Myeloma--drug therapy<br/>NF-kappa B--metabolism<br/>Transcription Factors--metabolism<br/>Treatment Outcome